Beijing First Hospital of integrated Chinese and Western Medicine   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Beijing China (1936)

Organization Overview

First Clinical Trial
2013
NCT02583802
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beijing First Hospital of integrated Chinese and Western Medicine

Active Ingredients

Drugs in Phase 4 Trials (2)

amoxicillin (1 trial)

reyanning (1 trial)

Drugs in Phase 3 Trials (4)

escitalopram (lexapro) (1 trial)

fructus schizandrae (1 trial)

ginseng (1 trial)

ophiochepalus striatus extract (1 trial)

Drugs in Phase 2 Trials (2)

bushen culuan (1 trial)

clomifene (clomid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anovulation (Phase 2)

Depression (Phase 3)

Depressive Disorder (Phase 3)

Hyperprolactinemia (Phase 2)

Hypotension (Phase 3)

Infertility (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Syndrome (Phase 2)

Tonsillitis (Phase 4)

Uterine Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8